Table 1.
Product type | Manufacturer and name | Suspected culprit allergen |
mRNA vaccine | Pfizer/BioNTech, BNT16262, BioNTechManufacturing GmbH Mainz Germany and Pfizer Manufacturing GmbH Puurs, Belgium, ‘Comirnaty’ COVID-19 Vaccine Moderna, Moderna Biotech Spain, Madrid, Spain | Polyethylene glycol (PEG-2000) |
Adenovirus vector vaccine | AstraZeneca, AZD1222, AstraZeneca AB, Södertälje, Sweden, ‘Vaxzevria’ COVID-19 Vaccine Janssen, Ad26.COV2-S, Janssen-Cilag International NV, Beerre, Belgium Sputnik V, Gamaleya Research Institute of Epidemiology and Mirobiology, Moscow, Russia | Polysorbate 80 |
Inactivated virus | BBIBP-CorV, Beijing Institute of Biological Products, Beijing, China, ‘Sinopharm’ | |
Recombinant spike protein | Novavax COVID-19 Vaccine, NVX-COV2373, Novavax Inc, Gaithersburg, Maryland, USA | Polysorbate 80 |
Note: BBIBP-CorV does not contain polyethylene glycol or polysorbate 80. PEG, polyethylene glycol.